Dulaglutide 10mg | 10-Vial Kit — Long-acting GLP-1 receptor agonist (LY2189265) — GLP-1 analogue fused to IgG4 Fc fragment for extended 7–14 day half-life, enabling once-weekly administration in research models. ≥99% HPLC purity, MS confirmed, Janoshik COA. Research use only.
Dulaglutide 10mg | 20-Vial Kit — Long-acting GLP-1 receptor agonist (LY2189265) — GLP-1 analogue fused to IgG4 Fc fragment for extended 7–14 day half-life, enabling once-weekly administration in research models. ≥99% HPLC purity, MS confirmed, Janoshik COA. Research use only.
Dulaglutide 5mg | 10-Vial Kit — Long-acting GLP-1 receptor agonist (LY2189265) — GLP-1 analogue fused to IgG4 Fc fragment for extended 7–14 day half-life, enabling once-weekly administration in research models. ≥99% HPLC purity, MS confirmed, Janoshik COA. Research use only.
Dulaglutide 5mg | 20-Vial Kit — Long-acting GLP-1 receptor agonist (LY2189265) — GLP-1 analogue fused to IgG4 Fc fragment for extended 7–14 day half-life, enabling once-weekly administration in research models. ≥99% HPLC purity, MS confirmed, Janoshik COA. Research use only.
EPO 10000 IU | 10-Vial Kit — Recombinant human erythropoietin (rhEPO) — glycoprotein cytokine activating EPOR on erythroid progenitors to stimulate red blood cell production, haemoglobin synthesis, and oxygen-carrying capacity. ≥99% HPLC purity, MS confirmed, Janoshik COA. Research use only.
EPO 10000 IU | 20-Vial Kit — Recombinant human erythropoietin (rhEPO) — glycoprotein cytokine activating EPOR on erythroid progenitors to stimulate red blood cell production, haemoglobin synthesis, and oxygen-carrying capacity. ≥99% HPLC purity, MS confirmed, Janoshik COA. Research use only.
EPO 3000 IU | 10-Vial Kit — Recombinant human erythropoietin (rhEPO) — glycoprotein cytokine activating EPOR on erythroid progenitors to stimulate red blood cell production, haemoglobin synthesis, and oxygen-carrying capacity. ≥99% HPLC purity, MS confirmed, Janoshik COA. Research use only.
EPO 3000 IU | 20-Vial Kit — Recombinant human erythropoietin (rhEPO) — glycoprotein cytokine activating EPOR on erythroid progenitors to stimulate red blood cell production, haemoglobin synthesis, and oxygen-carrying capacity. ≥99% HPLC purity, MS confirmed, Janoshik COA. Research use only.